Philips partners with Quibim to use their artificial intelligence software in prostate cancer MR exams
Philips se alía con Quibim para utilizar su software de inteligencia artificial en las resonancias de cáncer de próstata
Intel ID : 379298
Relevant Documents
| Press Release | 26 Oct 2023 | Philips_Press_Release_2023.pdf | EN |
|
| Intel ID | 379298 | |||
| Value | ND | |||
| Native Currency | Euro (EUR) | |||
|
Financial Data - Quibim
(31 Dec 2022) |
Revenue: - People: 70 |
|||
| Date |
 |
|||
| Country |  |
|||
| Geography | |
|||
| Subsector (Old TTR Sectors) |
|
|||
| Primary Subsector (TTRSC) |
15.03.01 Consumer Electronics (Primary) 15 Consumer Products & Services / 15.03 Consumer Durables 30.03.03 Diagnostic, Imaging & Laboratory Services (Primary) 30 Healthcare / 30.03 Healthcare Facilities & Services |
|||
| Secondary Subsectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
|||
| Type |
|
|||
| Intel Grade |
|
|||
| Source |
|
|||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
15.03.01 Consumer Electronics 15 Consumer Products & Services / 15.03 Consumer Durables |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.